GEODE CAPITAL MANAGEMENT, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1214717
BOSTON, MA
Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$62,480,460
+$7,428,433 QoQ
Shares Held
6,248,046
+8.0% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. BCRX ranks #15 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,480,460 | 6,248,046 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $55,052,027 | 5,782,776 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,419,530 | 5,053,786 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $38,347,009 | 5,052,307 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $45,289,305 | 5,054,610 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $37,204,777 | 4,960,637 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,274,486 | 4,823,735 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $36,768,686 | 4,837,985 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $29,109,511 | 4,710,277 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $22,353,376 | 4,400,271 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $25,521,221 | 4,260,638 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $27,690,425 | 3,911,077 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,981,187 | 3,832,555 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $30,470,657 | 3,653,556 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,795,994 | 3,466,550 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $42,409,634 | 3,365,844 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,725,221 | 3,282,157 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $53,364,962 | 3,281,978 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $44,575,892 | 3,218,476 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $45,114,600 | 3,139,499 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $49,209,605 | 3,112,562 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,413,618 | 2,990,523 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $19,788,161 | 2,656,129 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,406,369 | 2,443,712 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,523,183 | 2,210,753 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,407,356 | 2,203,678 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||